NAT2 and breast carcinoma: Several studies have indicated that the level of DNA adducts in breast tissues is higher among individuals with the slow NAT2 acetylator genotype, suggesting that slow NAT2 acetylators are more susceptible to adduct-induced DNA damage, which may subsequently contribute to higher risk of breast carcinoma [35].